Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Martin N. Wiseman, MD, FRCP, is a staff physician in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute, practicing at Hillcrest Hospital. He is board-certified in internal medicine, cardiovascular medicine and clinical cardiac electrophysiology, and his specialty interest is electrophysiology.
Dr. Wiseman is a graduate of the Medical School of St. Bartholomew’s Hospital, London, U.K. He completed his internship and residencies at St. Bartholomew’s Hospital and several other hospitals in the UK, including a research degree in cardiology at St. Bartholomew’s. He completed his subspecialty training with a fellowship in electrophysiology at The Philadelphia Heart Institute, Philadelphia, Pa.
Following completion of his fellowship, Dr. Wiseman was appointed to the medical staff at The Mt. Sinai Medical Center, Cleveland where he practiced until 1997. He subsequently joined the medical staff of University Hospitals of Cleveland as a staff electrophysiologist.
Since 2000 Dr. Wiseman has been a partner in Cardiovascular Associates of Cleveland, the position he held until his appointment to the Cleveland Clinic staff in 2011. From 1991 through 2004 he was an associate professor at Case Western Reserve University School of Medicine.
Dr. Wiseman is a member of the Heart Rhythm Society, a member and past Secretary of the North East Ohio Society of Pacing and Electrophysiology and a Fellow of the Royal College of Physicians of the United Kingdom.
Biventricular pacemaker, catheter ablation, electrophysiology study, pacemaker implant, radiofrequency ablation, abnormal heart rhythms, supraventricular tachycardia, heart block, atrial flutter, atrial fibrillation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/2/2013, Dr. Wiseman has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.